Surveillance for patients without adjuvant treatment (T1/2/3 N0 M0, well/moderately differentiated and no vascular invasion)
https://test.chelwest.risr.co.uk/your-visit/patient-leaflets/surgery-services/surveillance-for-patients-without-adjuvant-treatment-t1-2-3-n0-m0
https://test.chelwest.risr.co.uk/++resource++plone-logo.svg
Surveillance for patients without adjuvant treatment (T1/2/3 N0 M0, well/moderately differentiated and no vascular invasion)
| Date after treatment | CEA blood test | CT scan | Sigmoid-oscopy | MRI pelvis rectum | Colonoscopy |
| 3 months |
√ |
|
√ (TAMIS) |
|
|
| 6 months |
√ |
|
|
√ (TAMIS) |
√ (if polyps remaining after initial colonoscopy or not performed pre-op) |
| 9 months |
√ |
|
|
|
|
| 12 months |
√ |
√ |
|
√ (TAMIS or rectal) |
√ (then 2-yearly if Lynch syndrome/BSG guidelines if further polyps) |
| 18 months |
√ |
|
|
√ (TAMIS) |
|
| 24 months |
√ |
√ |
|
√ (TAMIS or rectal) |
|
| 30 months |
√ |
|
|
|
|
| 36 months |
√ |
√ |
|
|
|
| 42 months |
√ |
|
|
|
|
| 48 months |
√ |
√ |
|
|
√ |
| 54 months |
√ |
|
|
|
|
| 60 months |
√ |
√ |
|
|
|